Serum biomarker for progranulin‐associated frontotemporal lobar degeneration
暂无分享,去创建一个
K. Sleegers | C. van Broeckhoven | S. Engelborghs | R. Vandenberghe | W. Robberecht | P. van Damme | P. D. De Deyn | M. Cruts | N. Brouwers | J. van der Zee | K. Peeters | I. Gijselinck | M. Mattheijssens | P. D. de Deyn | Maria Mattheijssens
[1] K. Sleegers,et al. Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia , 2007, Human mutation.
[2] D. Geschwind,et al. Gene expression study on peripheral blood identifies progranulin mutations , 2008, Annals of neurology.
[3] J. Schneider,et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration , 2007, Acta Neuropathologica.
[4] P. Carmeliet,et al. Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival , 2008, The Journal of cell biology.
[5] R. Faber,et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.
[6] Holger Hummerich,et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia , 2005, Nature Genetics.
[7] C. Broeckhoven,et al. Progranulin variability has no major role in Parkinson disease genetic etiology , 2008, Neurology.
[8] K. Sleegers,et al. Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease , 2008, Neurology.
[9] C. Haass,et al. Missense Mutations in the Progranulin Gene Linked to Frontotemporal Lobar Degeneration with Ubiquitin-immunoreactive Inclusions Reduce Progranulin Production and Secretion* , 2008, Journal of Biological Chemistry.
[10] A. Bruni,et al. Novel PSEN1 and PGRN mutations in early-onset familial frontotemporal dementia , 2009, Neurobiology of Aging.
[11] B. Dubois,et al. Progranulin null mutations in both sporadic and familial frontotemporal dementia , 2007, Human mutation.
[12] S. Melquist,et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 , 2006, Nature.
[13] A. Pestronk,et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein , 2004, Nature Genetics.
[14] D. Neary,et al. TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer’s disease and frontotemporal lobar degeneration , 2008, Acta Neuropathologica.
[15] C. van Broeckhoven,et al. A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD. , 2006, Brain : a journal of neurology.
[16] G. Binetti,et al. Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration , 2008, Neurology.
[17] K. Sleegers,et al. Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family. , 2007, Archives of neurology.
[18] Marc Cruts,et al. Loss of progranulin function in frontotemporal lobar degeneration. , 2008, Trends in genetics : TIG.
[19] M. Grossman,et al. Frontotemporal lobar degeneration: recent progress in antemortem diagnosis , 2007, Acta Neuropathologica.
[20] B. Boeve,et al. Refining frontotemporal dementia with parkinsonism linked to chromosome 17: introducing FTDP-17 (MAPT) and FTDP-17 (PGRN). , 2008, Archives of neurology.
[21] Ronald C. Petersen,et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.
[22] Bruce L. Miller,et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.
[23] D. Geschwind,et al. Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C→T (Arg493X) mutation: an international initiative , 2007, The Lancet Neurology.
[24] C. Duijn,et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 , 2006, Nature.